Literature DB >> 3290944

Neuroleptic malignant syndrome.

S N Caroff, S C Mann.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3290944

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  21 in total

Review 1.  Psychiatry.

Authors:  K Granville-Grossman
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.

Authors:  Eric Brantley; Jamieson Cohn; Kavita Babu
Journal:  J Med Toxicol       Date:  2009-06

3.  Neuroleptic malignant syndrome with normal creatine kinase.

Authors:  R Singh; D Hassanally
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

4.  Neuroleptic malignant syndrome and the catatonic dilemma.

Authors:  Stanley N Caroff; Stephan C Mann; E Cabrina Campbell
Journal:  Psychopharmacology (Berl)       Date:  2015-01-16       Impact factor: 4.530

5.  Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?

Authors:  Deepali Dixit; Pranabh Shrestha; Marc Adelman
Journal:  BMJ Case Rep       Date:  2013-07-12

6.  Recovery and rechallenge after the neuroleptic malignant synorome.

Authors:  M P Chopra; R Raguram
Journal:  Indian J Psychiatry       Date:  2001-01       Impact factor: 1.759

7.  Resolution of symptoms in neuroleptic malignant syndrome.

Authors:  Yvonne D S Pereira; Ashish Srivastava; Bramhanand S Cuncoliencar; Nayana Naik
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

8.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

9.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

10.  Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.

Authors:  Daiji Kato; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Kyoko Suzuki; Hideki Onishi; Yoshio Hirayasu
Journal:  Eur J Clin Pharmacol       Date:  2007-08-14       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.